期刊文献+

番禺地区2011-2012年金黄色葡萄球菌的耐药性变化 被引量:2

The Change of Antibiotic Resistance of Staphylococcus Aureus in Panyu District Between 2011-2012
下载PDF
导出
摘要 目的:了解番禺地区2011-2012年间金黄色葡萄球菌的耐药性变化。方法:收集广州市番禺区中心医院2011-2012年从各类临床标本中分离出的金黄色葡萄球菌,用VITEK2 Compact及配套的鉴定卡GP与药敏卡AST-GP67进行检测,并用WHONET对其药敏结果进行统计分析。结果:2011年检出金黄色葡萄球菌623株,MRSA占342株(54.9%);2012年检出679株,MRSA占309株(45.5%),其中青霉素G、红霉素、苯唑西林2011年的耐药率分别是94.1%、62.5%、54.9%,2012年的耐药率分别是91.6%、54.5%、45.5%。未见对万古霉素、利奈唑胺、替加环素耐药的金黄色葡萄球菌。结论:了解和掌握本院金黄色葡萄球菌的分布和流行病学规律以及耐药变化状况,对指导临床合理选用抗菌药物,延缓细菌耐药株产生具有重要意义。 Objective:To know antibiotic resistance of Staphylococcus aureus in Pan Yu district between 2011 and 2012.Method:Various types of Staphylococcus aureus isolated from clinical specimens in Panyu district central hospital between 2011-2012 were collected,they were detected by VITEK2 Compact,GP and drug sensitive card AST-GP67,and the drug sensitivity results were analyzed by WHONET.Result:623 strains of Staphylococcus aureus was isolated in 2011,MRSA accounted for 342(54.9%);and 679 strains of Staphylococcus aureus was isolated in 2012,MRSA accounted for 309(45.5%),penicillin,oxacillin,erythromycin resistance rate was 94.1%,62.5%,54.9% respectively in 2011,and 91.6%, 54.5%,45.5%in 2012 respectively.No Vancomycin,linezolid and tigecycline resistant Staphylococcus aureus.Conclusion:It is important significance to understand and master the distribution and epidemiology of this hospital Staphylococcus aureus and resistance changes,to guide the clinical rational use of antimicrobial drugs,delay the bacteria resistant strains.
作者 林晓晖
出处 《中国医学创新》 CAS 2014年第2期113-116,共4页 Medical Innovation of China
基金 广州市番禺区科信局资助项目(2011Z0301)
关键词 金黄色葡萄球菌 耐药变化 MRSA Staphylococcus aureus Drug resistance MRSA
  • 相关文献

参考文献9

二级参考文献33

  • 1张洁.65株金黄色葡萄球菌耐药性分析[J].现代临床医学生物工程学杂志,2005,11(4):344-346. 被引量:6
  • 2刘敏,史莉,孙光成.耐甲氧西林凝固酶阴性葡萄球菌抗菌药物及消毒剂耐药基因研究[J].中华医院感染学杂志,2006,16(7):721-724. 被引量:19
  • 3杨永洁,彭丹心,刘建明.耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌医院感染调查分析[J].中华医院感染学杂志,2007,17(4):465-467. 被引量:56
  • 4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing [S]. Approved standard M100-S9. Wayne, Pennsylvania: NCCLS, 1999.1-103. 被引量:1
  • 5Nimmo GR, Bell J M, Mitchell D, et al. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals 1989-1999[J].Mierob Drug Resist, 2003,9 (2) : 155- 160. 被引量:1
  • 6Niitsuma K,Saitoh M,Kojimabara M,et al.Antimicrobial suscieptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture[J].J Jpn JAntibiot,2001,542:79-87. 被引量:1
  • 7Daniel A,Euler C,Collin M,et al.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant staphylococ-cus aureus[J].Antimicrob Agents Chemother,2010,54(4):1603-12. 被引量:1
  • 8Moubareck C,Meziane-Cherif D,Courvalin P,et al.VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on ancomycin for growth[J].Antimicrob Agents Chemother,2009,53(9):3657-63. 被引量:1
  • 9Micek ST.Alternatives to Vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections[J].Clinical infectious disease,2007,45(Suppl 3):184-190. 被引量:1
  • 10Ferrara AM.Treatment of hospital acquired pneumonia caused by methicillin-resistant Staphylococcus aureus[J].Int J Antimicrob Agents,2007,30(1):19-24. 被引量:1

共引文献116

同被引文献30

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部